FibroScan®
Webinar | 01.07.2023
Blog und News
topic :
category :
status :
Pressemeldung | 23.06.2023
Echosens und Novo Nordisk kündigen Kooperation an, um das Bewusstsein für NASH zu steigern und die Frühdiagnose voranzubringen
Webinar | 02.04.2023
Improving Management of Patients with Advanced Liver Disease Through Liver and Spleen Stiffness Assessment
Webinar | 02.04.2023
Current Perspectives in NAFLD-NASH Identification & Management – A Diabetologist’s Perspective
Pressemeldung | 02.04.2023
Innovative New Products and Technology Advancing Worldwide Liver Disease Management Highlight Echosens 20th Anniversary
Artikel | 29.11.2021
Liver Health Experts and Echosens Technology Featured on eHealth Radio Network
Webinar | 24.11.2021
AASLD Wrap Up; Key Lessons in NAFLD NASH Diagnostic Strategies
Artikel | 24.11.2021
Highlights from 2021 AASLD Liver Meeting: Early Detection and Monitoring with FibroScan® Mitigates Risk of Patients Developing Fibrosis/Cirrhosis
Artikel | 02.11.2021
Non-Invasive Point-of-Care Exam Helps Battle Liver Disease in Individuals with Obesity
Artikel | 02.04.2023
Link Between Non-alcoholic Fatty Liver Disease, Obesity and Liver Cancer Calls for Early Detection and Monitoring
Artikel | 12.08.2021
New EASL Clinical Practice Guidelines Make Unprecedented Recommendation for Non-Invasive FibroScan® and Care Management
Pressemeldung | 09.08.2021
Echosens Highlights New EASL Clinical Practice Guidelines
Artikel | 03.08.2021
Douglas Dieterich, M.D., discusses role of FibroScan® in the diagnoses of chronic liver disease
Artikel | 28.07.2023
Non-Invasive Liver Exam Identifies Asymptomatic Liver Disease, Provides Follow-Up for Hepatitis C Virus
Artikel | 26.07.2023